Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6810
-0.0114 (-1.65%)
At close: Apr 1, 2026, 4:00 PM EDT
0.6900
+0.0090 (1.32%)
After-hours: Apr 1, 2026, 4:50 PM EDT

Tenaya Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
100.554.3245.6895.2738.13
Short-Term Investments
-57.1258.9691.26213.17
Cash & Short-Term Investments
100.5561.45104.64186.53251.3
Cash Growth
63.63%-41.28%-43.90%-25.77%95.51%
Other Current Assets
5.045.936.947.234.06
Total Current Assets
105.5967.38111.58193.75255.36
Net Property, Plant & Equipment
37.0947.7553.2662.754.71
Long-Term Investments
---17.7-
Other Long-Term Assets
4.254.825.684.794.13
Total Assets
146.92119.94170.52278.95314.19
Accounts Payable
3.585.165.639.5810.72
Accrued Expenses
8.848.0412.7810.669.06
Current Portion of Leases
3.022.784.324.011.99
Total Current Liabilities
15.4415.9822.7324.2521.77
Long-Term Leases
7.8110.838.1111.0913.71
Other Long-Term Liabilities
0.410.280.250.230.18
Total Long-Term Liabilities
8.2211.118.3611.3213.89
Total Liabilities
23.6627.0931.0935.5735.66
Common Stock
0.020.010.010.010
Additional Paid-in Capital
728.25607.23542.81522.95434.2
Accumulated Other Comprehensive Income
-0.03-0.11-0.38-0.14
Retained Earnings
-605.01-514.41-403.28-279.2-155.53
Total Common Shareholders' Equity
123.2792.85139.42243.38278.53
Shareholders' Equity
123.2792.85139.42243.38278.53
Total Liabilities & Equity
146.92119.94170.52278.95314.19
Total Debt
10.8313.6112.4215.115.7
Net Cash (Debt)
89.7247.8492.22171.43235.6
Net Cash Growth
87.54%-48.13%-46.21%-27.24%89.98%
Net Cash Per Share
0.590.561.253.8313.29
Book Value
123.2792.85139.42243.38278.53
Book Value Per Share
0.811.091.895.4315.71
Tangible Book Value
123.2792.85139.42243.38278.53
Tangible Book Value Per Share
0.811.091.895.4315.71
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q